When it comes to health, prevention is naturally preferred to treatment. For stroke victims, recent medical device advances are providing the hope of preventing future attacks. Both the Watchman (approved for Boston Scientific by the FDA in 2015) and the Amplatzer PFO Occluder (approved for St. Jude in 2016) work to stop blood clots from reaching the heart and are… Read More
In 2016, the ever rising cost of healthcare generated some of the most intense public and political debates. Perhaps in no way was this better summarized than the sudden – and shocking – rise in the price of the EpiPen, a life-saving device dispensing epinephrine for the severely allergic. From a price of $100 in 2007, the cost skyrocketed to… Read More
Additive manufacturing, more commonly referred to as 3D Printing, appears set to have a major impact on medical device manufacturing. Pricing on the printers themselves has dropped steadily over the last several years, even while the technology behind them has become more refined.
There’s no doubt by now you’ve seen people staring at their smartphones in search of the fictional creatures from Pokémon. Behind the technology of this gaming sensation is opportunity within the medical industry. MDDI online has identified several applications for such technology: Patient Monitoring, PTSD Therapy, Prosthesis Training, Easing Patients’ Anxiety, Concussion Diagnosis, Vision Correction, Surgical Planning, and Surgical Training…. Read More
Nearly a month after the official British vote to leave the EU – also known as the Brexit – the decision still dominates the daily news. There has been a great deal of debate on the impact this will have on the British economy, but one area that could face particular difficulties is the pharmaceutical, medical device, and clinical research… Read More
The numbers are in for the first half of 2016 and as widely predicted, mergers and acquisitions are still a driving force in the medtech industry. Nearly 400 total agreements have been reached already, valuing almost $75.5billion. Following the shocking mega-merger of Medtronic and Covidien valued at $42.9 billiion in 2014 and an increase in sales and merging activity for… Read More